General MedicationsINJECTIONStandard
DAUNORUBICIN HYDROCHLORIDE
DAUNORUBICIN HYDROCHLORIDE
Standard Dose
EQ 5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview DAUNORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208759 (ANDA).
Marketing status: Prescription Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2020-12-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview DAUNORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208759 (ANDA). Marketing status: Prescription Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2020-12-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.